These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37383945)

  • 1. Immunoproteasomal Processing of Isolevuglandin Adducts in Hypertension.
    de la Visitación N; Chen W; Krishnan J; Van Beusecum JP; Amarnath V; Hennen EM; Zhao S; Saleem M; Ao M; Harrison DG; Patrick DM
    bioRxiv; 2023 Apr; ():. PubMed ID: 37383945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoproteasomal Processing of IsoLG-Adducted Proteins Is Essential for Hypertension.
    de la Visitación N; Chen W; Krishnan J; Van Beusecum JP; Amarnath V; Hennen EM; Zhao S; Saleem M; Ao M; Dikalov SI; Dikalova AE; Harrison DG; Patrick DM
    Circ Res; 2024 May; 134(10):1276-1291. PubMed ID: 38623763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
    Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
    Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolevuglandin-Modified Cardiac Proteins Drive CD4+ T-Cell Activation in the Heart and Promote Cardiac Dysfunction.
    Ngwenyama N; Kirabo A; Aronovitz M; Velázquez F; Carrillo-Salinas F; Salvador AM; Nevers T; Amarnath V; Tai A; Blanton RM; Harrison DG; Alcaide P
    Circulation; 2021 Mar; 143(12):1242-1255. PubMed ID: 33463362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.
    Xiao L; Patrick DM; Aden LA; Kirabo A
    Prostaglandins Other Lipid Mediat; 2018 Nov; 139():48-53. PubMed ID: 30278231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
    Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
    Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension.
    Prinsen JK; Kannankeril PJ; Sidorova TN; Yermalitskaya LV; Boutaud O; Zagol-Ikapitte I; Barnett JV; Murphy MB; Subati T; Stark JM; Christopher IL; Jafarian-Kerman SR; Saleh MA; Norlander AE; Loperena R; Atkinson JB; Fogo AB; Luther JM; Amarnath V; Davies SS; Kirabo A; Madhur MS; Harrison DG; Murray KT
    JACC Basic Transl Sci; 2020 Jun; 5(6):602-615. PubMed ID: 32613146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolevuglandin adducts in disease.
    Salomon RG; Bi W
    Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.
    May-Zhang LS; Yermalitsky V; Huang J; Pleasent T; Borja MS; Oda MN; Jerome WG; Yancey PG; Linton MF; Davies SS
    J Biol Chem; 2018 Jun; 293(24):9176-9187. PubMed ID: 29712723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.
    Longato L; Andreola F; Davies SS; Roberts JL; Fusai G; Pinzani M; Moore K; Rombouts K
    Free Radic Biol Med; 2017 Jan; 102():162-173. PubMed ID: 27890721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D.
    Guo L; Gragg SD; Chen Z; Zhang Y; Amarnath V; Davies SS
    J Lipid Res; 2013 Nov; 54(11):3151-7. PubMed ID: 24018423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified LC/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples.
    Yermalitsky VN; Matafonova E; Tallman K; Li Z; Zackert W; Roberts LJ; Amarnath V; Davies SS
    Anal Biochem; 2019 Feb; 566():89-101. PubMed ID: 30458125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation and Inhibition of the Immunoproteasome Catalytic Subunit LMP7 Attenuate Experimental Abdominal Aortic Aneurysm Formation in Mice.
    Li FD; Nie H; Tian C; Wang HX; Sun BH; Ren HL; Zhang X; Liao PZ; Liu D; Li HH; Zheng YH
    J Immunol; 2019 Feb; 202(4):1176-1185. PubMed ID: 30642978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted inhibition of the immunoproteasome blocks endothelial MHC class II antigen presentation to CD4
    Zhang Y; Yang X; Bi T; Wu X; Wang L; Ren Y; Ou Y; Xie C; Li K; Ran H; Wang J; Zhao F; Shui P; Qing J
    Int Immunopharmacol; 2022 Jun; 107():108639. PubMed ID: 35219165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis.
    Li J; Hu S; Johnson HWB; Kirk CJ; Xian P; Song Y; Li Y; Liu N; Groettrup M; Basler M
    Cardiovasc Res; 2023 May; 119(4):1030-1045. PubMed ID: 36464772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolevuglandin-protein adducts in oxidized low density lipoprotein and human plasma: a strong connection with cardiovascular disease.
    Salomon RG; Kaur K; Batyreva E
    Trends Cardiovasc Med; 2000 Feb; 10(2):53-9. PubMed ID: 11150730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.
    Guo L; Chen Z; Amarnath V; Yancey PG; Van Lenten BJ; Savage JR; Fazio S; Linton MF; Davies SS
    Antioxid Redox Signal; 2015 Jun; 22(18):1633-45. PubMed ID: 25751734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension.
    Dikalova A; Mayorov V; Xiao L; Panov A; Amarnath V; Zagol-Ikapitte I; Vergeade A; Ao M; Yermalitsky V; Nazarewicz RR; Boutaud O; Lopez MG; Billings FT; Davies S; Roberts LJ; Harrison DG; Dikalov S
    Hypertension; 2020 Dec; 76(6):1980-1991. PubMed ID: 33012204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation.
    Ruggeri Barbaro N; Van Beusecum J; Xiao L; do Carmo L; Pitzer A; Loperena R; Foss JD; Elijovich F; Laffer CL; Montaniel KR; Galindo CL; Chen W; Ao M; Mernaugh RL; Alsouqi A; Ikizler TA; Fogo AB; Moreno H; Zhao S; Davies SS; Harrison DG; Kirabo A
    Cardiovasc Res; 2021 Apr; 117(5):1358-1371. PubMed ID: 33038226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.
    Muchamuel T; Basler M; Aujay MA; Suzuki E; Kalim KW; Lauer C; Sylvain C; Ring ER; Shields J; Jiang J; Shwonek P; Parlati F; Demo SD; Bennett MK; Kirk CJ; Groettrup M
    Nat Med; 2009 Jul; 15(7):781-7. PubMed ID: 19525961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.